Search - tctmd.com

Displaying 401 - 420 of 624

Sort: Relevancy | Date

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Koen Deloose, William A. Gray, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Presenter: Koen Deloose, William A. Gray, Lawrence A. Garcia

November 01, 2016

Presentation TCT 2016

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

Presenter: Koen Deloose, William A. Gray

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Overview of the Clinical Trials for Drug-Coated Balloons

Presenter: Schuyler Jones, Misti Malone, George Papandreou

October 30, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

News Industry News

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

July 27, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Industry News

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

June 28, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

Presentation CCVVC 2016

Update on the Latest European and US Clinical Data on Drug Coated Balloons

Presenter: Fabrizio Fanelli

June 15, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

Advertisement

Designing a Complication-Free DCB: Is It Possible or Necessary?

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Overview of the Clinical Trials for Drug-Coated Balloons

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

TCTMD’s Top 10 Most Popular Stories for August 2016

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Update on the Latest European and US Clinical Data on Drug Coated Balloons

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content